Antibiotic-Loaded Hydroxyapatite Ceramic in the Management of Diabetic Foot Osteomyelitis: An Investigation of Factors That Determine Patient Outcomes
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- IDF Diabetes Atlas 2025. Diabetes Atlas. Available online: https://diabetesatlas.org/resources/idf-diabetes-atlas-2025/ (accessed on 9 March 2025).
- Boulton, A.J.M.; Armstrong, D.G.; Albert, S.F.; Frykberg, R.G.; Hellman, R.; Kirkman, M.S.; Lavery, L.A.; LeMaster, J.W.; Mills, J.L.; Mueller, M.J.; et al. Comprehensive Foot Examination and Risk Assessment: A Report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with Endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008, 31, 1679–1685. [Google Scholar] [CrossRef] [PubMed]
- Edo, A.; Edo, G.; Ezeani, I. Risk Factors, Ulcer Grade and Management Outcome of Diabetic Foot Ulcers in a Tropical Tertiary Care Hospital. Niger. Med. J. 2013, 54, 59. [Google Scholar] [CrossRef]
- Guest, J.F.; Fuller, G.W.; Vowden, P. Diabetic Foot Ulcer Management in Clinical Practice in the UK: Costs and Outcomes. Int. Wound J. 2017, 15, 43–52. [Google Scholar] [CrossRef] [PubMed]
- Armstrong, D.G.; Wrobel, J.; Robbins, J.M. Guest Editorial: Are Diabetes-Related Wounds and Amputations Worse than Cancer? Int. Wound J. 2007, 4, 286–287. [Google Scholar] [CrossRef]
- Singh, V.P.; Bali, A.; Singh, N.; Jaggi, A.S. Advanced Glycation End Products and Diabetic Complications. Korean J. Physiol. Pharmacol. 2014, 18, 1. [Google Scholar] [CrossRef]
- Vouillarmet, J.; Maucort-Boulch, D.; Michon, P.; Thivolet, C. Advanced Glycation End Products Assessed by Skin Autofluorescence: A New Marker of Diabetic Foot Ulceration. Diabetes Technol. Ther. 2013, 15, 601–605. [Google Scholar] [CrossRef]
- Armstrong, D.G.; Boulton, A.J.M.; Bus, S.A. Diabetic Foot Ulcers and Their Recurrence. N. Engl. J. Med. 2017, 376, 2367–2375. [Google Scholar] [CrossRef]
- Lavery, L.A.; Peters, E.J.G.; Armstrong, D.G.; Wendel, C.S.; Murdoch, D.P.; Lipsky, B.A. Risk Factors for Developing Osteomyelitis in Patients with Diabetic Foot Wounds. Diabetes Res. Clin. Pract. 2009, 83, 347–352. [Google Scholar] [CrossRef] [PubMed]
- Lavery, L.A.; Ryan, E.C.; Ahn, J.; Crisologo, P.A.; Oz, O.K.; La Fontaine, J.; Wukich, D.K. The Infected Diabetic Foot: Re-Evaluating the IDSA Diabetic Foot Infection Classification. Clin. Infect. Dis. 2019, 70, 1573–1579. [Google Scholar] [CrossRef]
- Thabit, A.K.; Fatani, D.F.; Bamakhrama, M.S.; Barnawi, O.A.; Basudan, L.O.; Alhejaili, S.F. Antibiotic Penetration into Bone and Joints: An Updated Review. Int. J. Infect. Dis. 2019, 81, 128–136. [Google Scholar] [CrossRef]
- Ferguson, J.; Athanasou, N.; Diefenbeck, M.; McNally, M. Radiographic and Histological Analysis of a Synthetic Bone Graft Substitute Eluting Gentamicin in the Treatment of Chronic Osteomyelitis. J. Bone Jt. Infect. 2019, 4, 76–84. [Google Scholar] [CrossRef] [PubMed]
- Metaoy, S.; Rusu, I.; Pillai, A. Adjuvant Local Antibiotic Therapy in the Management of Diabetic Foot Osteomyelitis. Clin. Diabetes Endocrinol. 2024, 10, 51. [Google Scholar] [CrossRef] [PubMed]
- NICE. Overview|Overweight and Obesity Management|Guidance|NICE. Nice.org.uk. Available online: https://www.nice.org.uk/guidance/ng246 (accessed on 9 March 2025).
- Braatvedt, G.D.; Cundy, T.; Crooke, M.; Florkowski, C.; Mann, J.I.; Lunt, H.; Jackson, R.; Orr-Walker, B.; Kenealy, T.; Drury, P.L. Understanding the New HbA1c Units for the Diagnosis of Type 2 Diabetes. N. Z. Med. J. 2012, 125, 70–80. [Google Scholar] [PubMed]
- Overview|Chronic Kidney Disease in Adults: Assessment and Management|Guidance|NICE. Nice.org.uk. Available online: https://www.nice.org.uk/guidance/cg182 (accessed on 9 March 2025).
- Meijer, W.T.; Hoes, A.W.; Rutgers, D.; Bots, M.L.; Hofman, A.; Grobbee, D.E. Peripheral Arterial Disease in the Elderly. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 185–192. [Google Scholar] [CrossRef]
- Drampalos, E.; Mohammad, H.R.; Kosmidis, C.; Balal, M.; Wong, J.; Pillai, A. Single Stage Treatment of Diabetic Calcaneal Osteomyelitis with an Absorbable Gentamicin-Loaded Calcium Sulphate/Hydroxyapatite Biocomposite: The Silo Technique. Foot 2018, 34, 40–44. [Google Scholar] [CrossRef]
- Niazi, N.S.; Drampalos, E.; Morrissey, N.; Jahangir, N.; Wee, A.; Pillai, A. Adjuvant Antibiotic Loaded Bio Composite in the Management of Diabetic Foot Osteomyelitis—A Multicentre Study. Foot 2019, 39, 22–27. [Google Scholar] [CrossRef]
- Toyofuku, M.; Inaba, T.; Kiyokawa, T.; Obana, N.; Yawata, Y.; Nomura, N. Environmental Factors That Shape Biofilm Formation. Biosci. Biotechnol. Biochem. 2015, 80, 7–12. [Google Scholar] [CrossRef]
- Mottola, C.; Matias, C.S.; Mendes, J.J.; Melo-Cristino, J.; Tavares, L.; Cavaco-Silva, P.; Oliveira, M. Susceptibility Patterns of Staphylococcus Aureus Biofilms in Diabetic Foot Infections. BMC Microbiol. 2016, 16, 119. [Google Scholar] [CrossRef]
- Adithan, C.; Sriram, G.; Swaminathan, R.P.; Shashindran, C.H.; Bapna, J.S.; Krishnan, M.; Chandrasekar, S. Differential Effect of Type I and Type II Diabetes Mellitus on Serum Ampicillin Levels. Int. J. Clin. Pharmacol. Ther. Toxicol. 1989, 27, 493–498. [Google Scholar]
- Fejfarová, V.; Antalová, S.; Husáková, J.; Wosková, V.; Beca, P.; Polák, J.; Dubský, M.; Sojáková, D.; Petrlík, M. Does PAD and Microcirculation Status Impact the Tissue Availability of Intravenously Administered Antibiotics in Patients with Infected Diabetic Foot? Results of the DFIATIM Substudy. Front. Endocrinol. 2024, 15, 1326179. [Google Scholar] [CrossRef]
- Stravinskas, M.; Horstmann, P.; Ferguson, J.; Hettwer, W.; Nilsson, M.; Tarasevicius, S.; Petersen, M.M.; McNally, M.A.; Lidgren, L. Pharmacokinetics of Gentamicin Eluted from a Regenerating Bone Graft Substitute. Bone Jt. Res. 2016, 5, 427–435. [Google Scholar] [CrossRef]
- Nilsson, M.; Wang, J.-S.; Wielanek, L.; Tanner, K.E.; Lidgren, L. Biodegradation and Biocompatability of a Calcium Sulphate-Hydroxyapatite Bone Substitute. J. Bone Jt. Surg.—Br. 2004, 86, 120–125. [Google Scholar] [CrossRef]
- Masala, S.; Nano, G.; Marcia, S.; Muto, M.; Paolo, F.; Simonetti, G. Osteoporotic Vertebral Compression Fractures Augmentation by Injectable Partly Resorbable Ceramic Bone Substitute (CeramentTM|SPINE SUPPORT): A Prospective Nonrandomized Study. Neuroradiology 2011, 54, 589–596. [Google Scholar] [CrossRef] [PubMed]
- Hatten, H.P.; Voor, M.J. Bone Healing Using a Bi-Phasic Ceramic Bone Substitute Demonstrated in Human Vertebroplasty and with Histology in a Rabbit Cancellous Bone Defect Model. Interv. Neuroradiol. 2012, 18, 105–113. [Google Scholar] [CrossRef] [PubMed]
- Guo, Q.; Ying, G.; Jing, O.; Zhang, Y.; Liu, Y.; Deng, M.; Long, S. Influencing Factors for the Recurrence of Diabetic Foot Ulcers: A Meta-Analysis. Int. Wound J. 2022, 20, 1762–1775. [Google Scholar] [CrossRef] [PubMed]
- Dubský, M.; Jirkovská, A.; Bem, R.; Fejfarová, V.; Skibová, J.; Schaper, N.C.; Lipsky, B.A. Risk Factors for Recurrence of Diabetic Foot Ulcers: Prospective Follow-up Analysis in the Eurodiale Subgroup. Int. Wound J. 2012, 10, 555–561. [Google Scholar] [CrossRef]
- Lin, C.; Liu, J.; Sun, H. Risk Factors for Lower Extremity Amputation in Patients with Diabetic Foot Ulcers: A Meta-Analysis. PLoS ONE 2020, 15, e0239236. [Google Scholar] [CrossRef]
- Ricci, L.; Scatena, A.; Tacconi, D.; Ventoruzzo, G.; Liistro, F.; Bolognese, L.; Monami, M.; Mannucci, E. All-Cause and Cardiovascular Mortality in a Consecutive Series of Patients with Diabetic Foot Osteomyelitis. Diabetes Res. Clin. Pract. 2017, 131, 12–17. [Google Scholar] [CrossRef]
- Wolf, G. New Insights into the Pathophysiology of Diabetic Nephropathy: From Haemodynamics to Molecular Pathology. Eur. J. Clin. Investig. 2004, 34, 785–796. [Google Scholar] [CrossRef]
- Sgonc, R.; Gruber, J. Age-Related Aspects of Cutaneous Wound Healing: A Mini-Review. Gerontology 2013, 59, 159–164. [Google Scholar] [CrossRef]
- Fife, C.E.; Horn, S.D.; Smout, R.J.; Barrett, R.S.; Thomson, B. A Predictive Model for Diabetic Foot Ulcer Outcome: The Wound Healing Index. Adv. Wound Care 2016, 5, 279–287. [Google Scholar] [CrossRef] [PubMed]
- Cotterell, A.; Griffin, M.; Downer, M.A.; Parker, J.B.; Wan, D.; Longaker, M.T. Understanding Wound Healing in Obesity. World J. Exp. Med. 2024, 14, 86898. [Google Scholar] [CrossRef]
- Faglia, E.; Favales, F.; Quarantiello, A.; Calia, P.; Clelia, P.; Brambilla, G.; Rampoldi, A.; Morabito, A. Angiographic Evaluation of Peripheral Arterial Occlusive Disease and Its Role as a Prognostic Determinant for Major Amputation in Diabetic Subjects with Foot Ulcers. Diabetes Care 1998, 21, 625–630. [Google Scholar] [CrossRef]
- Van Der Feen, C.; Neijens, F.S.; Kanters, S.D.J.M.; Mali, W.P.T.M.; Stolk, R.P.; Banga, J.D. Angiographic Distribution of Lower Extremity Atherosclerosis in Patients with and without Diabetes. Diabet. Med. 2002, 19, 366–370. [Google Scholar] [CrossRef] [PubMed]
- Guo, S.; DiPietro, L.A. Factors Affecting Wound Healing. J. Dent. Res. 2010, 89, 219–229. [Google Scholar] [CrossRef] [PubMed]
- Vella, L.; Gatt, A.; Formosa, C. Does Baseline Hemoglobin A1c Level Predict Diabetic Foot Ulcer Outcome or Wound Healing Time? J. Am. Podiatr. Med. Assoc. 2017, 107, 272–279. [Google Scholar] [CrossRef]
- Adler, A.I.; Boyko, E.J.; Ahroni, J.H.; Smith, D.G. Lower-Extremity Amputation in Diabetes. The Independent Effects of Peripheral Vascular Disease, Sensory Neuropathy, and Foot Ulcers. Diabetes Care 1999, 22, 1029–1035. [Google Scholar] [CrossRef]
- Maroz, N.; Simman, R. Wound Healing in Patients with Impaired Kidney Function. J. Am. Coll. Clin. Wound Spec. 2013, 5, 2–7. [Google Scholar] [CrossRef]
- Chen, L.; Sun, S.; Gao, Y.; Ran, X. Global Mortality of Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis of Observational Studies. Diabetes Obes. Metab. 2022, 25, 36–45. [Google Scholar] [CrossRef]
- Lee, K.M.; Kim, W.H.; Lee, J.H.; Choi, M.S.S. Risk Factors of Treatment Failure in Diabetic Foot Ulcer Patients. Arch. Plast. Surg. 2013, 40, 123–128. [Google Scholar] [CrossRef]
Infection Eradication | Infection Eradication Duration | Ulcer Healing | Ulcer- Healing Duration | Recurrence of Ulcer | Limb Salvage | Mortality | |
---|---|---|---|---|---|---|---|
Age | 0.51 | 0.43 | 0.20 | 0.04 | 0.75 | 0.26 | 0.28 |
Gender | 0.33 | 0.38 | 0.09 | 0.08 | 0.11 | 0.17 | 0.25 |
BMI | 0.54 | 0.04 | 0.74 | 0.11 | 0.16 | 0.28 | 0.18 |
Smoker | 0.33 | 0.18 | 0.18 | 0.19 | 0.07 | 0.18 | 0.29 |
Part of Foot | 0.20 | 0.56 | 0.32 | 0.72 | 0.23 | 0.15 | 0.73 |
Charcot | 0.46 | 0.55 | 0.43 | 0.29 | 0.18 | 0.24 | 0.08 |
PAD | 0.02 | 0.04 | 0.02 | 0.07 | 0.00 | 0.05 | 0.15 |
CKD | 0.38 | 0.22 | 0.63 | 0.40 | 0.31 | 0.27 | 0.00 |
HBA1C | 0.15 | 0.07 | 0.02 | 0.00 | 0.01 | 0.07 | 0.07 |
CRP | 0.34 | 0.19 | 0.17 | 0.09 | 0.01 | 0.27 | 0.02 |
Poly/Mono | 0.42 | 0.20 | 0.70 | 0.28 | 0.33 | 0.35 | 0.51 |
Gram Stain | 0.58 | 0.22 | 0.92 | 0.12 | 0.22 | 0.26 | 0.87 |
Antibiotics | 0.22 | 0.38 | 0.36 | 0.03 | 0.13 | 0.86 | 0.76 |
Cerament | 0.28 | 0.09 | 0.13 | 0.21 | 0.19 | 0.21 | 0.09 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tai, K.M.; Mooteeram, J.; Metaoy, S.; Pillai, A. Antibiotic-Loaded Hydroxyapatite Ceramic in the Management of Diabetic Foot Osteomyelitis: An Investigation of Factors That Determine Patient Outcomes. BioMed 2025, 5, 11. https://doi.org/10.3390/biomed5020011
Tai KM, Mooteeram J, Metaoy S, Pillai A. Antibiotic-Loaded Hydroxyapatite Ceramic in the Management of Diabetic Foot Osteomyelitis: An Investigation of Factors That Determine Patient Outcomes. BioMed. 2025; 5(2):11. https://doi.org/10.3390/biomed5020011
Chicago/Turabian StyleTai, Ken Meng, Justin Mooteeram, Sara Metaoy, and Anand Pillai. 2025. "Antibiotic-Loaded Hydroxyapatite Ceramic in the Management of Diabetic Foot Osteomyelitis: An Investigation of Factors That Determine Patient Outcomes" BioMed 5, no. 2: 11. https://doi.org/10.3390/biomed5020011
APA StyleTai, K. M., Mooteeram, J., Metaoy, S., & Pillai, A. (2025). Antibiotic-Loaded Hydroxyapatite Ceramic in the Management of Diabetic Foot Osteomyelitis: An Investigation of Factors That Determine Patient Outcomes. BioMed, 5(2), 11. https://doi.org/10.3390/biomed5020011